National Health Research Institutes, Taiwan
Clinical trials sponsored by National Health Research Institutes, Taiwan, explained in plain language.
-
New drug duo takes on tough bile duct cancer in first-line trial
Disease control Not yet recruitingThis study tests whether adding two immunotherapy drugs (nivolumab and relatlimab) to standard chemotherapy works better than chemo plus just one immunotherapy for advanced bile duct cancer. About 76 adults who have not had prior treatment for their advanced cancer will take part…
Phase: PHASE2 • Sponsor: National Health Research Institutes, Taiwan • Aim: Disease control
Last updated May 17, 2026 02:06 UTC
-
New hope for liver cancer patients after immunotherapy fails
Disease control Not yet recruitingThis study tests the drug cabozantinib in 60 adults with advanced liver cancer that worsened after initial immunotherapy. The goal is to see if cabozantinib can stop or slow tumor growth for at least 6 months. Researchers will also look for blood and tissue markers that predict r…
Phase: PHASE2 • Sponsor: National Health Research Institutes, Taiwan • Aim: Disease control
Last updated May 12, 2026 13:39 UTC
-
Can a website replace the Therapist's couch? new study tests online CBT for anxiety and depression
Symptom relief Not yet recruitingThis study tests if an online therapy program (ICBT) can help adults with generalized anxiety disorder or major depressive disorder feel better. About 160 participants will either get their usual care or usual care plus an 8-week online program with 12 modules. The goal is to see…
Phase: NA • Sponsor: National Health Research Institutes, Taiwan • Aim: Symptom relief
Last updated May 12, 2026 13:40 UTC